Skip to main content
Top
Published in: Modern Rheumatology 4/2012

01-08-2012 | Original Article

Definitive differences in laboratory and radiological characteristics between two subtypes of juvenile idiopathic arthritis: systemic arthritis and polyarthritis

Authors: Remi Ozawa, Yutaka Inaba, Masaaki Mori, Ryoki Hara, Masako Kikuchi, Rumiko Higuchi, Takako Miyamae, Tomoyuki Imagawa, Takeo Fujiwara, Tomoyuki Saito, Shumpei Yokota

Published in: Modern Rheumatology | Issue 4/2012

Login to get access

Abstract

We performed this study to investigate the differences in radiological and laboratory findings between systemic juvenile idiopathic arthritis (s-JIA) and polyarthritis (p-JIA). Twenty-two patients with s-JIA and 18 with p-JIA were enrolled. Their laboratory findings and radiographs were examined retrospectively. Plain radiographs were obtained before the induction of biological agents. All radiographs were examined for the presence of soft tissue swelling, juxta-articular osteopenia, joint space narrowing, subchondral bone cyst, erosion, epiphyseal irregularity, and growth abnormalities. Carpal length and bone mineral density of the lumbar spine, an indicator of generalized osteoporosis, were also investigated in all the patients enrolled. Laboratory examinations involved white blood cell counts, platelets, C-reactive protein (CRP), rheumatoid factor (RF), anti-cyclic citrullinated peptide (CCP) antibody, and matrix metalloproteinase (MMP)-3. Comparisons of the laboratory findings between s-JIA and p-JIA indicated that the titers of anti-CCP antibody and RF were significantly increased in p-JIA sera (P < 0.05). There was no difference in BMD between the two groups of patients. Carpal length was significantly shorter in p-JIA patients than in s-JIA patients (P < 0.05). The most frequent radiological abnormality in s-JIA was juxta-articular osteopenia (93.8%), in comparison to a frequency of 50.0% in p-JIA. Joint space narrowing was shown in 9.8% of the s-JIA patients compared to 35.7% of the p-JIA patients. Subchondral bone cyst and erosion were more frequent in p-JIA than s-JIA. In conclusion, there were differences in radiographic characteristics and laboratory data between s-JIA and p-JIA in this study. In the radiological evaluation, bone-related abnormality was prominent in s-JIA and joint-related abnormality was striking in p-JIA, and these results indicated that the pathogenic bases of arthritis appear to differ between these two subtypes of JIA.
Literature
1.
go back to reference Cassidy JT, Petty RE. Chronic arthritis, poly arthritis, oligoarthritis, systemic arthritis. In: Cassidy JT, Petty RE, Laxer RM, Linsley CB, editors. Textbook of pediatric rheumatology. 5th ed. Philadelphia: Elsevier Saunders; 2005. p. 206–303. Cassidy JT, Petty RE. Chronic arthritis, poly arthritis, oligoarthritis, systemic arthritis. In: Cassidy JT, Petty RE, Laxer RM, Linsley CB, editors. Textbook of pediatric rheumatology. 5th ed. Philadelphia: Elsevier Saunders; 2005. p. 206–303.
2.
go back to reference Fink CW. Proposal for the development of classification criteria for the idiopathic arthritides of childhood. J Rheumatol. 1995;22:1566–9.PubMed Fink CW. Proposal for the development of classification criteria for the idiopathic arthritides of childhood. J Rheumatol. 1995;22:1566–9.PubMed
3.
go back to reference Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol. 1998;25:1991–4.PubMed Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol. 1998;25:1991–4.PubMed
4.
go back to reference Yokota S, Miyamae T, Imagawa T, Iwata N, Katakura S, Mori M. Inflammatory cytokines and systemic-onset juvenile idiopathic arthritis. Mod Rheumatol. 2004;14:12–7.PubMedCrossRef Yokota S, Miyamae T, Imagawa T, Iwata N, Katakura S, Mori M. Inflammatory cytokines and systemic-onset juvenile idiopathic arthritis. Mod Rheumatol. 2004;14:12–7.PubMedCrossRef
5.
go back to reference Ramanan AV, Grom AA. Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis? Rheumatology. 2005;44:1350–3.PubMedCrossRef Ramanan AV, Grom AA. Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis? Rheumatology. 2005;44:1350–3.PubMedCrossRef
6.
go back to reference Lovell DJ. Update on treatment of arthritis in children–new treatment, new goals. Bull Hosp Jt Dis. 2006;64:72–6. Lovell DJ. Update on treatment of arthritis in children–new treatment, new goals. Bull Hosp Jt Dis. 2006;64:72–6.
7.
go back to reference Yokota S, Imagawa T, Mori M, Miyamae T, Aihara Y, Takei S, et al. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet. 2008;371:998–1006.PubMedCrossRef Yokota S, Imagawa T, Mori M, Miyamae T, Aihara Y, Takei S, et al. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet. 2008;371:998–1006.PubMedCrossRef
8.
go back to reference Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, et al. Etanercept in children with polyarticular juvenile idiopathic arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med. 2000;342:763–9.PubMedCrossRef Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, et al. Etanercept in children with polyarticular juvenile idiopathic arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med. 2000;342:763–9.PubMedCrossRef
9.
go back to reference van Rossum MA, Zwinderman AH, Boers M, Dijkmans BA, van Soesbrqen RM, Fiselier TJ, et al. Radiologic features in juvenile idiopathic arthritis: a first step in the development of a standardized assessment method. Arthritis Rheum. 2003;48:507–15.PubMedCrossRef van Rossum MA, Zwinderman AH, Boers M, Dijkmans BA, van Soesbrqen RM, Fiselier TJ, et al. Radiologic features in juvenile idiopathic arthritis: a first step in the development of a standardized assessment method. Arthritis Rheum. 2003;48:507–15.PubMedCrossRef
10.
go back to reference Pozanski AK, Hernandez RJ, Guire KE, Bereza VL, Garn SM. Carpal length in children: a useful measurement in the diagnosis of rheumatoid arthritis and some congenital malformation syndromes. Radiology. 1978;129:661–8. Pozanski AK, Hernandez RJ, Guire KE, Bereza VL, Garn SM. Carpal length in children: a useful measurement in the diagnosis of rheumatoid arthritis and some congenital malformation syndromes. Radiology. 1978;129:661–8.
11.
go back to reference Inamo Y, Harada K. Normal range of carpal length in Japanese children. Nihon Univ J Med. 1998;40:81–7. Inamo Y, Harada K. Normal range of carpal length in Japanese children. Nihon Univ J Med. 1998;40:81–7.
12.
go back to reference Nishiyama S, Kiwaki K, Inomoto T, Seino Y. Bone mineral density of the lumbar spine and total body mass in Japanese children and adolescents. J Jpn Pediatr Soc. 1999;103:1131–8. Nishiyama S, Kiwaki K, Inomoto T, Seino Y. Bone mineral density of the lumbar spine and total body mass in Japanese children and adolescents. J Jpn Pediatr Soc. 1999;103:1131–8.
13.
go back to reference Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc. 1949;140:659–62.PubMedCrossRef Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc. 1949;140:659–62.PubMedCrossRef
14.
go back to reference Sharp JT, Lidsky MD, Collins LC, Moreland J. Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities. Arthritis Rheum. 1971;14:706–20.PubMedCrossRef Sharp JT, Lidsky MD, Collins LC, Moreland J. Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities. Arthritis Rheum. 1971;14:706–20.PubMedCrossRef
15.
go back to reference Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh). 1977;18:481–91. Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh). 1977;18:481–91.
16.
go back to reference van der Heijge D, Dnakert T, Nieman F, Rau R, Boers M. Reliability and sensitivity to change of simplification of the Sharp/van der Heijge radiological assessment in rheumatoid arthritis. J Rheumatol. 1999;38:941–7.CrossRef van der Heijge D, Dnakert T, Nieman F, Rau R, Boers M. Reliability and sensitivity to change of simplification of the Sharp/van der Heijge radiological assessment in rheumatoid arthritis. J Rheumatol. 1999;38:941–7.CrossRef
17.
go back to reference Gravallese EM. Bone destruction in arthritis. Ann Rheum Dis. 2002;61:84–6. Gravallese EM. Bone destruction in arthritis. Ann Rheum Dis. 2002;61:84–6.
18.
go back to reference Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, et al. Involvement of receptor activator of nuclear factor κB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum. 2000;43:259–69.PubMedCrossRef Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, et al. Involvement of receptor activator of nuclear factor κB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum. 2000;43:259–69.PubMedCrossRef
19.
go back to reference Haynes DR, Crotti TN, Loric M, Bain GI, Atkins GJ, Findlay DM. Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. Rheumatology. 2001;40:623–30.PubMedCrossRef Haynes DR, Crotti TN, Loric M, Bain GI, Atkins GJ, Findlay DM. Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. Rheumatology. 2001;40:623–30.PubMedCrossRef
20.
go back to reference Pettit AR, Walsh NC, Manninq C, Goldrinq SR, Gravallese EM. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis. Rheumatology. 2006;45:1068–76.PubMedCrossRef Pettit AR, Walsh NC, Manninq C, Goldrinq SR, Gravallese EM. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis. Rheumatology. 2006;45:1068–76.PubMedCrossRef
21.
go back to reference Varsani H, Patel A, van Kooyk Y, Woo P, Wedderburn LR. Synovial dendritic cells in juvenile idiopathic arthritis (JIA) express receptor activator of NF-κB (RANK). Rheumatology. 2003;42:583–90.PubMed Varsani H, Patel A, van Kooyk Y, Woo P, Wedderburn LR. Synovial dendritic cells in juvenile idiopathic arthritis (JIA) express receptor activator of NF-κB (RANK). Rheumatology. 2003;42:583–90.PubMed
22.
go back to reference Masi L, Simonini G, Piscitelli E, Del Monte F, Giani T, Cimaz R, et al. Osteoprotegerin (OPG)/RANK-L system in juvenile idiopathic arthritis: is there a potential modulating role for OPG/RANK-l in bone injury? J Rheumatol. 2004;31:986–91.PubMed Masi L, Simonini G, Piscitelli E, Del Monte F, Giani T, Cimaz R, et al. Osteoprotegerin (OPG)/RANK-L system in juvenile idiopathic arthritis: is there a potential modulating role for OPG/RANK-l in bone injury? J Rheumatol. 2004;31:986–91.PubMed
23.
go back to reference Sarma PK, Misra R, Aqqarwal A. Elevated serum receptor activator of NF-κB ligand (RANKL), osteoprotegerin (OPG), matrix metalloproteinase (MMP)3, and ProMMP1 in patients with juvenile idiopathic arthritis. Clin Rheumatol. 2008;27:289–94.PubMedCrossRef Sarma PK, Misra R, Aqqarwal A. Elevated serum receptor activator of NF-κB ligand (RANKL), osteoprotegerin (OPG), matrix metalloproteinase (MMP)3, and ProMMP1 in patients with juvenile idiopathic arthritis. Clin Rheumatol. 2008;27:289–94.PubMedCrossRef
24.
go back to reference Aggarwal P, Aggarwal A, Gupta S, Misra R. Osteopenia is common in adult male patients with active juvenile idiopathic arthritis. J Rheumatol. 2006;33:1642–5.PubMed Aggarwal P, Aggarwal A, Gupta S, Misra R. Osteopenia is common in adult male patients with active juvenile idiopathic arthritis. J Rheumatol. 2006;33:1642–5.PubMed
25.
go back to reference Okumus O, Erguven M, Deveci M, Yilmaz O, Okumus M. Growth and bone mineralization in patients with juvenile idiopathic arthritis. Indian J Pediatr. 2008;75:239–43.PubMedCrossRef Okumus O, Erguven M, Deveci M, Yilmaz O, Okumus M. Growth and bone mineralization in patients with juvenile idiopathic arthritis. Indian J Pediatr. 2008;75:239–43.PubMedCrossRef
26.
go back to reference Henderson CJ, Cawkwell GD, Specker BL, Sierra RI, Wilmott RW, Campaiqne BN, et al. Predictors of total body bone mineral density in non-corticosteroid-treated prepubertal children with juvenile rheumatoid arthritis. Arthritis Rheum. 1997;40:1967–75.PubMedCrossRef Henderson CJ, Cawkwell GD, Specker BL, Sierra RI, Wilmott RW, Campaiqne BN, et al. Predictors of total body bone mineral density in non-corticosteroid-treated prepubertal children with juvenile rheumatoid arthritis. Arthritis Rheum. 1997;40:1967–75.PubMedCrossRef
27.
go back to reference Henderson CJ, Specker BL, Sierra RI, Campaiqne BN, Lovell DJ. Total-body bone mineral content in non-corticosteroid treated postpubertal females with juvenile rheumatoid arthritis: frequency of osteopenia and contributing factors. Arthritis Rheum. 2000;43:531–40.PubMedCrossRef Henderson CJ, Specker BL, Sierra RI, Campaiqne BN, Lovell DJ. Total-body bone mineral content in non-corticosteroid treated postpubertal females with juvenile rheumatoid arthritis: frequency of osteopenia and contributing factors. Arthritis Rheum. 2000;43:531–40.PubMedCrossRef
28.
go back to reference Hartman C, Shamir R, Eshach-Adiv O, losilevsky G, Brik R. Assessment of osteoporosis by quantitative ultrasound versus dual energy X-ray absorptiometry in children with chronic rheumatic disease. J Rheumatol. 2004;31:981–5.PubMed Hartman C, Shamir R, Eshach-Adiv O, losilevsky G, Brik R. Assessment of osteoporosis by quantitative ultrasound versus dual energy X-ray absorptiometry in children with chronic rheumatic disease. J Rheumatol. 2004;31:981–5.PubMed
29.
go back to reference De Benedetti F, Rucci N, Del Fattore A, Peruzzi B, Paro R, Lonqo M, et al. Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system. Arthritis Rheum. 2006;54:3551–63.PubMedCrossRef De Benedetti F, Rucci N, Del Fattore A, Peruzzi B, Paro R, Lonqo M, et al. Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system. Arthritis Rheum. 2006;54:3551–63.PubMedCrossRef
Metadata
Title
Definitive differences in laboratory and radiological characteristics between two subtypes of juvenile idiopathic arthritis: systemic arthritis and polyarthritis
Authors
Remi Ozawa
Yutaka Inaba
Masaaki Mori
Ryoki Hara
Masako Kikuchi
Rumiko Higuchi
Takako Miyamae
Tomoyuki Imagawa
Takeo Fujiwara
Tomoyuki Saito
Shumpei Yokota
Publication date
01-08-2012
Publisher
Springer Japan
Published in
Modern Rheumatology / Issue 4/2012
Print ISSN: 1439-7595
Electronic ISSN: 1439-7609
DOI
https://doi.org/10.1007/s10165-011-0540-6

Other articles of this Issue 4/2012

Modern Rheumatology 4/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine